Literature DB >> 16316377

Thrombocytopenia induced by nicotinamide in hemodialysis patients.

Jacques B Rottembourg, Vincent Launay-Vacher, Julien Massard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16316377     DOI： 10.1111/j.1523-1755.2005.00583_8.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  9 in total

1.  Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis.

Authors:  Radwa El Borolossy; Lamia Mohamed El Wakeel; Ihab El Hakim; Nagwa Sabri
Journal:  Pediatr Nephrol       Date:  2015-09-29       Impact factor: 3.714

Review 2.  Niacin and analogs for phosphate control in dialysis--perspective from a developing country.

Authors:  Krishnaswamy Sampathkumar
Journal:  Int Urol Nephrol       Date:  2008-11-27       Impact factor: 2.370

Review 3.  Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond?

Authors:  Grace J Lee; Joanne Marks
Journal:  Pediatr Nephrol       Date:  2014-02-05       Impact factor: 3.714

Review 4.  Nicotinamide and phosphate homeostasis in chronic kidney disease.

Authors:  Charles Ginsberg; Joachim H Ix
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

Review 5.  Use of nicotinamide to treat hyperphosphatemia in dialysis patients.

Authors:  Aurélie Lenglet; Sophie Liabeuf; Pauline Guffroy; Albert Fournier; Michel Brazier; Ziad A Massy
Journal:  Drugs R D       Date:  2013-09

Review 6.  N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin.

Authors:  Aurélie Lenglet; Sophie Liabeuf; Sandra Bodeau; Loïc Louvet; Aurélien Mary; Agnès Boullier; Anne Sophie Lemaire-Hurtel; Alexia Jonet; Pascal Sonnet; Said Kamel; Ziad A Massy
Journal:  Toxins (Basel)       Date:  2016-11-15       Impact factor: 4.546

7.  Nicotinic acid and related compounds: A meta-analysis of their use for hyperphosphatemia in dialysis patients.

Authors:  Xianhua Liu; Ruiheng Yang; Bo Dai; Honghao Zhang; Jinxue Wang; Ning Ma
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

8.  Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial.

Authors:  Markus Ketteler; Andrzej Wiecek; Alexander R Rosenkranz; Andreas Pasch; Jan Rekowski; Burkhard Hellmann; Michael Karus; Richard Ammer
Journal:  Kidney Int Rep       Date:  2020-12-19

9.  Biological Efficacy and Safety of Niacinamide in Patients With ADPKD.

Authors:  Mireille El Ters; Xia Zhou; Rebecca J Lepping; Pengcheng Lu; Rainer T Karcher; Jonathan D Mahnken; William M Brooks; Franz T Winklhofer; Xiaogang Li; Alan S L Yu
Journal:  Kidney Int Rep       Date:  2020-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.